Found: 59
Select item for more details and to access through your institution.
Plasma lysophosphatidic acid concentration and ovarian cancer.
- Published in:
- 2002
- By:
- Publication type:
- commentary
Enhancement of Sphingomyelinase-Induced Endothelial Nitric Oxide Synthase-Mediated Vasorelaxation in a Murine Model of Type 2 Diabetes.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 9, p. 8375, doi. 10.3390/ijms24098375
- By:
- Publication type:
- Article
Sphingosine-1-Phosphate Enhances α1-Adrenergic Vasoconstriction via S1P2–G12/13–ROCK Mediated Signaling.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 24, p. 6361, doi. 10.3390/ijms20246361
- By:
- Publication type:
- Article
Correction to: Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Role of autotaxin in cancer stem cells.
- Published in:
- Cancer & Metastasis Reviews, 2018, v. 37, n. 2/3, p. 509, doi. 10.1007/s10555-018-9745-x
- By:
- Publication type:
- Article
Location, location, location: a crystal-clear view of autotaxin saturating LPA receptors.
- Published in:
- Nature Structural & Molecular Biology, 2011, v. 18, n. 2, p. 117, doi. 10.1038/nsmb0211-117
- By:
- Publication type:
- Article
Functional modulation of lysophosphatidic acid type 2 G‐protein coupled receptor facilitates alveolar bone formation.
- Published in:
- Journal of Cellular Physiology, 2024, v. 239, n. 1, p. 112, doi. 10.1002/jcp.31148
- By:
- Publication type:
- Article
Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis.
- Published in:
- Scientific Reports, 2016, p. 27050, doi. 10.1038/srep27050
- By:
- Publication type:
- Article
Doxycycline Inducible Kruppel-Like Factor 4 Lentiviral Vector Mediates Mesenchymal to Epithelial Transition in Ovarian Cancer Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0105331
- By:
- Publication type:
- Article
Pharmacological Characterization of Phospholipid Growth-Factor Receptors.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 34, doi. 10.1111/j.1749-6632.2000.tb06536.x
- By:
- Publication type:
- Article
Characterization of Endogenous and Heterologously Expressed LPA Receptor Subtypes.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 287, doi. 10.1111/j.1749-6632.2000.tb06562.x
- By:
- Publication type:
- Article
Structural Features of EDG1 Receptor-Ligand Complexes Revealed by Computational Modeling and Mutagenesis.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 330, doi. 10.1111/j.1749-6632.2000.tb06573.x
- By:
- Publication type:
- Article
Stimulation of Platelets and Endothelial Cells by Mildly Oxidized LDL Proceeds through Activation of Lysophosphatidic Acid Receptors and the Rho/Rho-Kinase Pathway: Inhibition by Lovastatin.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 282, doi. 10.1111/j.1749-6632.2000.tb06561.x
- By:
- Publication type:
- Article
Topical Application of LPA Accelerates Wound Healing.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 270, doi. 10.1111/j.1749-6632.2000.tb06558.x
- By:
- Publication type:
- Article
Sphingosylphosphorylcholine Is a Bona Fide Mediator Regulating Heart Rate.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 308, doi. 10.1111/j.1749-6632.2000.tb06567.x
- By:
- Publication type:
- Article
Phospholipid Growth Factors and Corneal Wound Healing.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 142, doi. 10.1111/j.1749-6632.2000.tb06546.x
- By:
- Publication type:
- Article
Quantitative Analysis of Lysophosphatidic Acid in Human Blood Fractions.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 267, doi. 10.1111/j.1749-6632.2000.tb06557.x
- By:
- Publication type:
- Article
A Novel Lipid Mediator, Cyclic Phosphatidic Acid (cPA), and Its Biological Functions.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 905, n. 1, p. 319, doi. 10.1111/j.1749-6632.2000.tb06570.x
- By:
- Publication type:
- Article
Thrombogenic and atherogenic activities of lysophosphatidic acid.
- Published in:
- Journal of Cellular Biochemistry, 2004, v. 92, n. 6, p. 1086, doi. 10.1002/jcb.20108
- By:
- Publication type:
- Article
Lysophospholipids and their G protein‐coupled receptors in biology and diseases.
- Published in:
- Journal of Cellular Biochemistry, 2004, v. 92, n. 5, p. 867, doi. 10.1002/jcb.20186
- By:
- Publication type:
- Article
Prometastatic Effect of ATX Derived from Alveolar Type II Pneumocytes and B16-F10 Melanoma Cells.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1586, doi. 10.3390/cancers14061586
- By:
- Publication type:
- Article
Regulation of Tumor Immunity by Lysophosphatidic Acid.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1202, doi. 10.3390/cancers12051202
- By:
- Publication type:
- Article
Novel Inhibitory Effect of a Lysophosphatidic Acid 2 Agonist on Allergen-Driven Airway Inflammation.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2016, v. 54, n. 3, p. 402, doi. 10.1165/rcmb.2015-0124OC
- By:
- Publication type:
- Article
Novel Autotaxin Inhibitor ATX-1d Significantly Enhances Potency of Paclitaxel—An In Silico and In Vitro Study.
- Published in:
- Molecules, 2024, v. 29, n. 18, p. 4285, doi. 10.3390/molecules29184285
- By:
- Publication type:
- Article
Designing Dual Inhibitors of Autotaxin-LPAR GPCR Axis.
- Published in:
- Molecules, 2022, v. 27, n. 17, p. 5487, doi. 10.3390/molecules27175487
- By:
- Publication type:
- Article
Adipose-Derived Stem Cells Facilitate Ovarian Tumor Growth and Metastasis by Promoting Epithelial to Mesenchymal Transition Through Activating the TGF-β Pathway.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.756011
- By:
- Publication type:
- Article
Paneth cell dysfunction in radiation injury and radio-mitigation by human α-defensin 5.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1174140
- By:
- Publication type:
- Article
E2F7 drives autotaxin/Enpp2 transcription via chromosome looping: Repression by p53 in murine but not in human carcinomas.
- Published in:
- FASEB Journal, 2023, v. 37, n. 7, p. 1, doi. 10.1096/fj.202300838R
- By:
- Publication type:
- Article
LPAR2 receptor activation attenuates radiation-induced disruption of apical junctional complexes and mucosal barrier dysfunction in mouse colon.
- Published in:
- FASEB Journal, 2020, v. 34, n. 9, p. 11641, doi. 10.1096/fj.202000544R
- By:
- Publication type:
- Article
LPA<sub>1</sub> receptor-mediated thromboxane A<sub>2</sub> release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.
- Published in:
- FASEB Journal, 2017, v. 31, n. 4, p. 1547, doi. 10.1096/fj.201600735R
- By:
- Publication type:
- Article
Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis.
- Published in:
- FASEB Journal, 2015, v. 29, n. 9, p. 3638, doi. 10.1096/fj.14-261289
- By:
- Publication type:
- Article
Specific nonlipid agonists of the lysophosphatidic acid type 2 GPCR with subnanomolar potency mitigate radiation injury (998.2).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.998.2
- By:
- Publication type:
- Article
Lysophosphatidic acid induces vasodilation mediated by LPA<sub>1</sub> receptors, phospholipase C, and endothelial nitric oxide synthase.
- Published in:
- FASEB Journal, 2014, v. 28, n. 2, p. 880, doi. 10.1096/fj.13-234997
- By:
- Publication type:
- Article
Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif.
- Published in:
- FEBS Journal, 2014, v. 281, n. 4, p. 1017, doi. 10.1111/febs.12674
- By:
- Publication type:
- Article
Lysophosphatidic acid-activated Cl− current activity in human systemic sclerosis skin fibroblasts.
- Published in:
- Rheumatology, 2010, v. 49, n. 12, p. 2290, doi. 10.1093/rheumatology/keq260
- By:
- Publication type:
- Article
Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1.
- Published in:
- FASEB Journal, 2006, v. 20, n. 3, p. 509, doi. 10.1096/fj.05-4810fje
- By:
- Publication type:
- Article
Mitigation of the Hematopoietic and Gastrointestinal Acute Radiation Syndrome by Octadecenyl Thiophosphate, a Small Molecule Mimic of Lysophosphatidic Acid.
- Published in:
- Radiation Research, 2015, v. 183, n. 4, p. 465, doi. 10.1667/RR13830.1
- By:
- Publication type:
- Article
Conservation of miR-15a/16-1 and miR-15b/16-2 clusters.
- Published in:
- Mammalian Genome, 2010, v. 21, n. 1/2, p. 88, doi. 10.1007/s00335-009-9240-3
- By:
- Publication type:
- Article
Osteoclast‐Derived Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1801, doi. 10.1002/art.41005
- By:
- Publication type:
- Article
Aiming drug discovery at lysophosphatidic acid targets.
- Published in:
- 2010
- By:
- Publication type:
- journal article
EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway.
- Published in:
- Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00578-5
- By:
- Publication type:
- Article
Autotaxin–lysophosphatidic acid receptor 5 axis evokes endothelial dysfunction via reactive oxygen species signaling.
- Published in:
- Experimental Biology & Medicine, 2023, v. 248, n. 20, p. 1887, doi. 10.1177/15353702231199081
- By:
- Publication type:
- Article
Revisiting the role of lysophosphatidic acid in stem cell biology.
- Published in:
- Experimental Biology & Medicine, 2021, v. 246, n. 16, p. 1802, doi. 10.1177/15353702211019283
- By:
- Publication type:
- Article
Prevention and treatment of secretory diarrhea by the lysophosphatidic acid analog Rx100.
- Published in:
- Experimental Biology & Medicine, 2018, v. 243, n. 13, p. 1056, doi. 10.1177/1535370218803349
- By:
- Publication type:
- Article
Benzyl and Naphthalene Methylphosphonic Acid Inhibitors of Autotaxin with Anti-invasive and Anti-metastatic Activity.
- Published in:
- ChemMedChem, 2011, v. 6, n. 5, p. 922, doi. 10.1002/cmdc.201000425
- By:
- Publication type:
- Article
Alkoxymethylenephosphonate Analogues of (Lyso)phosphatidic Acid Stimulate Signaling Networks Coupled to the LPA<sub>2</sub> Receptor.
- Published in:
- ChemMedChem, 2008, v. 3, n. 2, p. 200, doi. 10.1002/cmdc.200890006
- By:
- Publication type:
- Article
Alkoxymethylenephosphonate Analogues of (Lyso)phosphatidic Acid Stimulate Signaling Networks Coupled to the LPA<sub>2</sub> Receptor.
- Published in:
- ChemMedChem, 2007, v. 2, n. 12, p. 1789, doi. 10.1002/cmdc.200700111
- By:
- Publication type:
- Article
α-Substituted Phosphonate Analogues of Lysophosphatidic Acid (LPA) Selectively Inhibit Production and Action of LPA.
- Published in:
- ChemMedChem, 2007, v. 2, n. 5, p. 679, doi. 10.1002/cmdc.200600280
- By:
- Publication type:
- Article
Phosphorothioate Analogues of Alkyl Lysophosphatidic Acid as LPA<sub>3</sub> Receptor-Selective Agonists.
- Published in:
- ChemMedChem, 2006, v. 1, n. 3, p. 376, doi. 10.1002/cmdc.200500042
- By:
- Publication type:
- Article